Publication | Closed Access

Rehmannioside A improves cognitive impairment and alleviates ferroptosis via activating PI3K/AKT/Nrf2 and SLC7A11/GPX4 signaling pathway after ischemia

Molecular NeuroscienceMedicineNeurochemical BiomarkersNeuroprotectionNeurosciencePharmacologySynaptic SignalingSocial SciencesOxidative Stress